Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

about

Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea.

P2860

Q47839838-946D4EA3-1358-4265-BF63-159CAE0192A0

P2860

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

Item

http://www.wikidata.org/entity/Q35618080

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@ast

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@en

type

Item

label

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@ast

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@en

prefLabel

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@ast

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@en

P1476

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

@en

P2093

Cordula Mohrlang

http://www.w3.org/2001/XMLSchema#string

David B Rubin

http://www.w3.org/2001/XMLSchema#string

Gerd Hasenfuß

http://www.w3.org/2001/XMLSchema#string

Helge Haarmann

http://www.w3.org/2001/XMLSchema#string

Karin Rüter

http://www.w3.org/2001/XMLSchema#string

Slavtcho Bonev

http://www.w3.org/2001/XMLSchema#string

Stefan Andreas

http://www.w3.org/2001/XMLSchema#string

Thore Bornemann

http://www.w3.org/2001/XMLSchema#string

Tobias Raupach

http://www.w3.org/2001/XMLSchema#string

Uta Tschiesner

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic obstructive pulmonary disease

Hormones and hemodynamics in heart failure.

Percent emphysema, airflow obstruction, and impaired left ventricular filling.

β2-agonist therapy in lung disease.

The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.

Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure.

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.

Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD

Neurohumoral activation as a link to systemic manifestations of chronic lung disease.

Reflex regulation of airway smooth muscle tone.

P2888

s12890-015-0054-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-015-0054-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerd P. Hasenfuß

P577

2015-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275668670

http://www.w3.org/2001/XMLSchema#string

P6179

1023928526

http://www.w3.org/2001/XMLSchema#string

P698

25924990

http://www.w3.org/2001/XMLSchema#string

P932

4460951

http://www.w3.org/2001/XMLSchema#string

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

about

P2860

P2860

Inhaled β-agonist does not modify sympathetic activity in patients with COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932